KRISTEN MARQUIS: Open Payments
NPI 1487384657 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,350 in 112 payments from 17 companies in 2025. Trend: 2023 $1,969 · 2024 $1,686 · 2025 $2,350
Food & beverage: $2,350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $546 |
| Teva Pharmaceuticals USA, Inc. | 8 | $253 |
| Axsome Therapeutics, Inc. | 12 | $191 |
| Janssen Pharmaceuticals, Inc | 10 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $175 |
| Otsuka America Pharmaceutical, Inc. | 7 | $146 |
| Neurocrine BioSciences, Inc. | 6 | $131 |
| Alkermes, Inc. | 4 | $102 |
| Lundbeck LLC | 4 | $89 |
Products named: VRAYLAR, AUSTEDO XR, REXULTI, Auvelity, SPRAVATO, CAPLYTA, TRINTELLIX, INGREZZA.
Industry payments across NY — which companies pay providers there.
